首页 | 本学科首页   官方微博 | 高级检索  
检索        

99mTc标记的大肠癌单克隆抗体在小鼠体内分布特点的研究
引用本文:徐凌燕,赵金彩,毛一卿,张春丽,李慧,张雅丽,牛刚,阮元,谭焕然.99mTc标记的大肠癌单克隆抗体在小鼠体内分布特点的研究[J].中国临床药理学与治疗学,2004,9(7):739-743.
作者姓名:徐凌燕  赵金彩  毛一卿  张春丽  李慧  张雅丽  牛刚  阮元  谭焕然
作者单位:1. 北京大学医学部基础医学院药理学系,北京100083
2. 中国人民解放军305医院核医学科,北京,100017
3. 北京大学第一医院核医学科,北京,100034
4. 北京牛牛基因技术有限公司,北京,100088
基金项目:国家科技部生命科学技术发展中心新药基金项目 (№ 96 90 1 0 5 197),北京市科学技术委员会科技基金项目 (№ 95 5 5 10 0 5 0 0 )
摘    要:目的:研究^99m-Tc标记的大肠癌单克隆抗体(^99mTc—ACCmAb)在正常小鼠和荷瘤裸鼠体内的分布及在荷瘤裸鼠体内SPECT成像的研究。方法:将^99m-Tc和^99mTc—ACCmAb分别注射入正常小鼠、荷L010-16人结肠癌裸鼠,按不同时间点采取小鼠的脏器进行同位素放射性活度的测定;并在不同时间测定荷L010-16人结肠癌裸鼠注射^99mTc—ACCmAb的SPECT显像。结果:注射^99mTc后正常小鼠体内6h5min血液中的放射性活度与30min相比下降了76.6%,是30min的23.4%;肝脏中6h5min的放射性活度为30min的27.2%,下降了72.8%。尾静脉注射^99mTc-ACCmAb的正常小鼠,6h5min在血液中的放射性活度与30min血液中的放射性活度比较下降了68.4%,是30min的31.6%,24h为6h5min的6.1%,下降了93.9%;荷瘤裸鼠体内^99mTc-ACCmAb在24h血液中的放射性活度是6h5min的2.1%,下降了97.9%。SPECT显像结果表明,虽然在注射^99mTc-ACCmAb20h血液与肿瘤的比值为最高,但在24h的成像结果仍然好于其他的时间点。结论:^99m-Tc标记的大肠癌单克隆抗体可特异性浓聚于荷L010-16人结肠癌裸鼠模型中,可能成为大肠癌根除手术中使用的手术导向体内诊断用药,保证手术切除肿瘤的彻底性。

关 键 词:抗大肠癌单克隆抗体(^99mTc-ACCmAb)  大肠癌  分布  成像实验
文章编号:1009-2501(2004)07-0739-05
修稿时间:2004年4月13日

Biodistribution characteristics of 99mTc labeled anti-colon cancer monoclonal antibody in mice
XU Ling-Yan,ZHAO Jing-Cai ,MAOYi-Qing,ZHANG Chun-Li ,LI Hui,ZHANG Ya-li,NIU Gang ,RUAN Yuan,TAN Huan- Ran.Biodistribution characteristics of 99mTc labeled anti-colon cancer monoclonal antibody in mice[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2004,9(7):739-743.
Authors:XU Ling-Yan  ZHAO Jing-Cai  MAOYi-Qing  ZHANG Chun-Li  LI Hui  ZHANG Ya-li  NIU Gang  RUAN Yuan  TAN Huan- Ran
Institution:XU Ling-Yan,ZHAO Jing-Cai 1,MAOYi-Qing,ZHANG Chun-Li 2,LI Hui,ZHANG Ya-li,NIU Gang 3,RUAN Yuan,TAN Huan- Ran Department of Pharmacology,School of Basic Medical Sciences,Health Science Center,Peking University,Beijing 100083,China, 1 Department of Nuclear Medicine,305 Hospital of PLA,Beijing 100017,China, 2 Department of Nuclear Medicine,First Hospital,Peking University,Beijing 100034,China, 3 Beijing N&N Genetech Company,Beijing 100088,China
Abstract:AIM: To study the biodistribution of 99m Tc labeled Anti-colon cancer monoclonal antibody ( 99mTc-ACCmAb ) in normal and nude mice and the imaging of same antibody in nude mice, which were carried with human colon cancer. METHODS: Normal mice and Nude mice that are carried the L010-16 human colon cancer received, intravenously, 99m Tc labeled monoclonal antibodies, and then the radioactivity was detected in normal mice in different time points and the imaging was checked by using the SPECT in nude mice. RESULTS: The radioactivity of 99m Tc at 6 h 5 min decreased 76.6% in comparison with the 30 min in normal mice blood, and the radioactivity was the 23.4% of the 30 min in the blood. The radioactivity in 6 h 5 min was 27.2% of the 30 min in normal mice liver and decreased 76.8%. In the normal mice injected 99m Tc-ACCmAb, the radioactivity at 6 h 5 min decreased 68.4% compared with the 30 min in normal mice blood, the radioactivity was the 31.6% of the 30 min in the blood, the radioactivity at 24 h are 6.1% and it dropped 93.9% compare with the 6 h 5 min. In nude mice, the radioactivity of 99m Tc-ACCmAb at 24 h is 2.1% of the first half-life. It decreased 97.9% compared with the 6 h 5 min. Although the ratio of blood and tumor was the highest, the imaging results were still better than other time points. CONCLUSION: 99m Tc-ACCmAb may concentrate in nude mice, which are carried with human colon carcinoma. It may become the diagnostic reagent for radio-immunoguided and ensure to remove the tumor during operations.
Keywords:mTc-ACCmAb  colon cancer  distribution  SPECT radio-imaging
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号